Mechanisms that underlie the patterning of cytokine expression in T helper (T H ) cell subsets remain incompletely defined. An evolutionarily conserved ∼400-bp noncoding sequence in the intergenic region between the genes Il4 and Il13, designated conserved noncoding sequence 1 (CNS-1), was deleted in mice.The capacity to develop T H 2 cells was compromised in vitro and in vivo in the absence of CNS-1. Despite the profound effect in T cells, mast cells from CNS-1 -/-mice maintained their capacity to produce interleukin 4. A T cell-specific element critical for the optimal expression of type 2 cytokines may represent the evolution of a regulatory sequence exploited by adaptive immunity. . Stabilization of cytokine gene expression patterns has been associated with structural changes in the chromatin around expressed genes [3] [4] [5] [6] . Such changes may allow the access of lineage-determining transcription factors, such as GATA-3 for TH2 cells and T-bet for TH1 cells 7, 8 . A DNase I hypersensitivity site that appears during the differentiation of TH2 cells identified an enhancer element 3´ of Il4 that selectively recruits GATA-3, which focuses the more generally expressed NFAT1 transcription factors at the Il4 promoter and enhancer sequences 9 . Identification of such critical elements will lead to an understanding of how cell fate decisions are intricately linked with host responses in the immune system. In a screen for potential regulatory elements, ∼1 mb of human chromosome 5q31 and the orthologous region on mouse chromosome 11 were compared for conserved noncoding sequences (CNSs). With the use of criteria associated with experimentally identified regulatory regions, which were longer than 100 bp with >70% homology 10 , 91 elements were located within intergenic regions. At 401 bp, CNS-1 was the longest of these elements; additional sequence comparison revealed substantial conservation across mammals, including mice, humans, cows, dogs and rabbits
Mechanisms that underlie the patterning of cytokine expression in T helper (T H ) cell subsets remain incompletely defined. An evolutionarily conserved ∼400-bp noncoding sequence in the intergenic region between the genes Il4 and Il13, designated conserved noncoding sequence 1 (CNS-1), was deleted in mice.The capacity to develop T H 2 cells was compromised in vitro and in vivo in the absence of CNS-1. Despite the profound effect in T cells, mast cells from CNS-1 -/-mice maintained their capacity to produce interleukin 4. A T cell-specific element critical for the optimal expression of type 2 cytokines may represent the evolution of a regulatory sequence exploited by adaptive immunity. 
Deletion of a coordinate regulator of type 2 cytokine expression in mice
Elucidation of the mechanisms by which naïve T cells acquire their functional cytokine repertoire is critical to understanding how different types of antigenic challenge are met with discrete immune responses. Cytokines are crucial in this process: they stabilize the expression of certain cytokine genes while suppressing others, which leads to the eventual development of polarized populations of effector cells best suited for different types of infectious organism. The most prevalent polarized T helper (TH) cell subsets, TH1 cells, which are characterized by interferon-γ (IFN-γ) production, and TH2 cells, which are characterized by interleukin 4 (IL-4) production, develop in response to the cytokines IL-12 and IL-4, respectively. The cytokine signals are mediated by critical signal transducers and activators of transcription (STAT) factors, which are associated with their relevant cytokine receptors on naïve T cells 1 . Cytokine genes occupy transcriptionally permissive areas in the nuclei of naïve T cells, where STAT signals may serve to stabilize patterns of cytokine gene transcription initiated by antigen receptor signaling 2 . Stabilization of cytokine gene expression patterns has been associated with structural changes in the chromatin around expressed genes [3] [4] [5] [6] . Such changes may allow the access of lineage-determining transcription factors, such as GATA-3 for TH2 cells and T-bet for TH1 cells 7, 8 . A DNase I hypersensitivity site that appears during the differentiation of TH2 cells identified an enhancer element 3´ of Il4 that selectively recruits GATA-3, which focuses the more generally expressed NFAT1 transcription factors at the Il4 promoter and enhancer sequences 9 . Identification of such critical elements will lead to an understanding of how cell fate decisions are intricately linked with host responses in the immune system. In a screen for potential regulatory elements, ∼1 mb of human chromosome 5q31 and the orthologous region on mouse chromosome 11 were compared for conserved noncoding sequences (CNSs). With the use of criteria associated with experimentally identified regulatory regions, which were longer than 100 bp with >70% homology 10 , 91 elements were located within intergenic regions. At 401 bp, CNS-1 was the longest of these elements; additional sequence comparison revealed substantial conservation across mammals, including mice, humans, cows, dogs and rabbits 11 . The localization of CNS-1 between IL4 and IL13, the cytokine products of which were coordinately expressed by individual alleles in appropriately activated T cells 12 , suggested a potential regulatory role for CNS-1 in modulating cytokine expression. In the absence of CNS-1, not only human IL4 and IL13, but Targeting construct: the CNS-1 element was replaced by a loxP-flanked neomycin selection cassette (neo). Mutated locus: integration of the targeting construct. Mutated locus after Cre recombination: Cre-mediated excision of the neo cassette in the germ line resulted in the final arrangement.Triangles, loxP sites; H, HindIII; K, KpnI; N, NotI; tk, thymidine kinase expression cassette. (b) Southern analysis for correct integration of the targeting construct and germ line transmission of the mutated allele. Genomic DNA was prepared from tail biopsies of mice, digested with HindIII, separated by electrophoresis and transferred onto membranes.The blot was hybridized with probe B.The wild-type locus resulted in an 8.8-kb fragment and the targeted locus in a 6.6-kb fragment. (c) Southern blot analysis for deletion of the neo cassette and the CNS-1 element. Genomic DNA was prepared as in b, but digested with KpnI, and hybridized with probe C.The wild-type locus resulted in a 1.8-kb fragment and the CNS-1 and neo-deleted locus in a 1.3-kb fragment. ch, chimera. also IL5, located 120 kb from IL13 across the intervening RAD50 gene, were attenuated in expression in mouse transgenic T cells 11 . We generated CNS-1 -/-mice to test directly whether this element was involved in expression of the type 2 cytokines in vitro and in vivo. The results establish that CNS-1 is a crucial element in the expression of type 2 cytokines in T lymphocytes and validate interspecies genomic comparisons as a mechanism for finding critical elements involved in gene regulation linked to cell differentiation 13 .
Results

Generation of CNS-1-deficient mice
CNS-1 was deleted in embryonic stem cells by homologous recombination and replacement with a loxP-flanked drug selection cassette (Fig. 1a) . After obtaining germ line transmission in targeted mice, animals were bred with mice that expressed Cre recombinase in the germ line, and offspring were screened for deletion of the selection cassette. Male CNS-1 +/-mice were bred with female BALB/c mice. Offspring were selected that carried deletions of CNS-1 and the neomycin selection cassette together with absence of the cre transgene (Fig. 1a-c) . The net effect of targeting the CNS-1 element was the replacement of 489 bp, including the CNS-1 sequence, with 255 bp of vector sequence containing one residual loxP site. Animals were crossed to obtain homozygous CNS-1 -/-mice, which were healthy and had no obvious phenotypic differences from wild-type animals. Analysis of thymus, lymph nodes and spleen showed no impact of CNS-1 deletion on the development or number of thymic or peripheral lymphoid cell populations (data not shown).
Type 2 cytokine expression in CNS-1 -/-cells in vitro
Highly purified, naïve CD4 + T cells (>99% CD62L hi ) from wild-type and heterozygous and homozygous CNS-1 -/-mice were labeled with the intracellular fluorochrome carboxyfluorescein diacetate succinimidyl ester (CFSE), and stimulated with antibodies to the T cell antigen receptor (TCR) and CD28 under TH1, neutral (no added polarizing cytokines) or TH2 conditions. After 4 days, the cells proliferated heterogeneously (in agreement with published data 2 ) and populations were distributed in groups from zero to six divisions (Fig. 2a) . Deletion of CNS-1 had no effect on cell progression through division.
Cells were analyzed on day 4 by intracellular staining for IL-4 and IFN-γ expression after restimulation with phorbol 12-myristate 13-acetate (PMA) + ionomycin. Under TH2 conditions, CNS-1 -/-cells showed fewer IL-4-expressing cells in each cell division and less IL-4 production per cell, as assessed by the mean fluorescence intensity (MFI) (Fig. 2b) . Heterozygous CNS-1 +/-cells had an intermediate phenotype. After 5 days of priming under TH2 conditions, CNS-1 -/-T cells produced not only less IL-4, but also less IL-5 and IL-13, as assessed by enzyme-linked immunosorbent assay (ELISA) of culture supernatants 48 h after restimulation (Fig. 2c) . Under neutral or TH1 conditions, CNS-1 -/-cells showed no differences from wild-type T cells: IFN-γ concentrations were equivalent under either condition and IL-4 production was minimal (data not shown).
The activation of naïve T cells by plate-bound TCR and CD28 antibodies results in a rapid transcription of Il4, as assessed by the quantitative kinetic reverse transcription polymerase chain reaction (RT-PCR) 2 . Compared with wild-type CD4 + T cells, CNS-1 -/-cells showed a delayed appearance of IL-4 transcripts (Fig. 3a) . Although CNS-1 -/-cells increased the production of IL-4 transcripts over the subsequent 20 h, a reduction in transcript abundance continued; cells examined after 5 days in culture had similarly reduced IL-4 mRNA (Fig. 3b) .
Mast cells produce IL-4 via mechanisms distinct from those of T cells. Although STAT6, GATA-3 and c-Maf are all critical for the production of IL-4 by T cells, none of these factors is required by mast cells [14] [15] [16] . To test the requirement for CNS-1 in mast cell IL-4 production, bone marrow-derived mast cells from wild-type and homozygous CNS-1 -/-mice were stimulated with ionomycin and analyzed for IL-4 production by enzyme-linked immunospot (ELISPOT) assays. Under these conditions, there was no difference from wild-type cells in the number of IL-4-producing cells or the amount of IL-4 produced using CNS-1 -/-mast cells, despite the ease with which differences were seen using CNS-1 -/-T cells (Fig. 4) . Thus, at least under these conditions, mast cells, in contrast to T cells, do not require the CNS-1 element for optimal IL-4 expression.
Type 2 cytokines in vivo in CNS-1 -/-mice
IL-4 and, to a lesser extent, IL-13 induce immunoglobulin (Ig) isotype switching to IgE 17 . Wild-type, heterozygous and homozygous CNS-1 -/-littermates were examined for baseline IgE. The presence of CNS-1 was correlated with serum IgE concentration, which suggested a role for this element in mediating TH2 cytokine expression in vivo (Fig. 5) .
To explore further the effects of CNS-1 deletion in vivo, mice were infected with Nippostrongylus brasiliensis, a strong inducer of TH2 immune responses 18 . After 8 days, lymphoid cells from the lung and mesenteric lymph nodes were purified and examined for IL-4 expression by intracellular cytokine staining. Whether collected from tissue lung sites or lymph nodes, CD4 + T cells from CNS-1 -/-mice contained fewer IL-4-producing cells with a lower MFI per cell than wild-type mice did (Fig. 6) . Intratracheal challenge with extracts of the fungus Aspergillus fumigatus induces a strong lung TH2 immune response in mice and has been used to model allergic airways diseases such as asthma 19 . Challenged mice develop enhanced airway reactivity to bronchoconstricting agents and show an elevation in serum IgE that is associated with the infiltration of IL-4-and IL-5-producing CD4 + T cells into the lungs. Cohorts of age-matched mice were challenged with A. fumigatus and analyzed 4 days after the final antigen dose. Both IL-4-producing and IL-5-producing CD4 + T cells were attenuated in CNS-1 -/-mice (Fig. 7a) . The induction of bronchial reactivity to acetylcholine was slightly less and serum IgE was diminished in CNS-1 -/-mice (Fig. 7b,c) . Leishmania major is an intracellular protozoon contained in the host by TH1 cells that produce IFN-γ. The capacity to clear parasites is blocked by TH2 cells that produce IL-4. Mouse strains can range from having highly resistant TH1-associated responses to highly susceptible TH2 responses; the degree of TH2 responsiveness is inversely correlated with the capacity to clear parasitic infection 20 . Age-matched, wild-type and CNS-1 -/-mice were infected in the hind footpads with L. major, and the size of footpad lesions was followed over the subsequent 6 weeks. Footpads from CNS-1 -/-mice were smaller than those from wild-type mice and correlated directly with a lower number of parasites being recovered from tissues (Fig. 8a,b) . When assessed by ELISPOT assays, CNS-1 -/-popliteal lymph nodes draining the lesions contained fewer IL-4-producing cells than those from wild-type mice (Fig. 8c) . Serum IgE concentrations were also reduced (Fig. 8d) .
Discussion
CNS-1 is a 401-bp element located in the IL4 and IL13 intergenic region that shares 89% homology between mice and humans 11 . Deletion of this sequence results in no apparent effects on lymphoid development in mice. As assessed both in vitro and in vivo with the use of three distinct antigenic challenges, however, CNS-1 was required for optimal expression of the TH2 cytokines. Although the expression of IL-4 was investigated most thoroughly, both IL-13 and IL-5 were attenuated under various conditions. This study both validates an indirect approach with human YAC (yeast artificial chromosome) transgenes to investigate the role of CNS-1 in the control of TH2 cytokine expression, and implicates this region as an element that regulates the expression of these cytokines in vitro and in vivo 11 . Extensive mutational analysis has linked the cell-and activationdependent expression of IL-4 to proximal promoter elements [21] [22] [23] . Five NFAT binding sites, two associated with AP-1 family members, are required for inducible IL-4 expression in vitro [24] [25] [26] . Although NFAT and AP-1 proteins are not TH2-specific, knockout studies of NFATc1 and JunB have implicated these members of the respective protein families in the optimal differentiation of TH2 cells [27] [28] [29] . Despite these findings, Il4 promoter-transgenic mice expressed the transgene in much smaller amounts than they expressed endogenous Il4, which implicated additional regulatory elements beyond the promoter region 30 . DNase I hypersensitivity analysis identified a 3´ Il4 enhancer that served to recruit GATA-3, a TH2 lineage differentiation factor 7 , during TH2 polarization in vitro. This distal enhancer increased Il4 promoter-driven transcription approximately twofold in vitro, although no in vivo studies were done 9 . With the use of a transgenic approach, a mini-locus that included CNS-1 functioned as a strong enhancer for the Il4 promoter, although TH2-specific expression required linkage with additional proximal elements 31 . Whereas the deletion of CNS-1 caused a distinct phenotype, the secretion of TH2 cytokines was not ablated entirely. Whether this was because of the strong stimulus used (cross-linking antibodies to the TCR and CD28) or whether it revealed the presence of alternate, but less efficient, mechanisms for activation of these genes will require further study. There was no requirement for CNS-1 for activating IL-4 expression in mast cells. Three independent models of antigenic challenge, however, verified the need for CNS-1 for optimal TH2 differentiation. N. brasiliensis infection and inhalation challenge with A. fumigatus represent strong stimuli for TH2 cell differentiation; in each case, deficiency of CNS-1 was associated with reduced numbers of cells expressing TH2 cytokines. Indirect effects of cytokine expression, such as class switching to IgE, were clearly affected by the lack of this regulatory sequence. In vivo TH2 cytokine responses were attenuated but not entirely absent. This diminished capacity to produce TH2 cytokines may reflect CNS-1-independent pathways, albeit less efficient ones, in mast cells or other cell types. Similar observations have been made with STAT6
-/-T cells: although IL-4 expression was substantially attenuated, some cells stochastically progressed through the requirement for STAT6 and subsequently achieved stable IL-4 expression 32 . In the L. major model, a CD4 + T cell-dependent system in which susceptibility was linked tightly with TH2 development, the absence of CNS-1 was associated with a robust phenotype that enhanced the capacity of mice to resolve this intracellular infection. Thus, pharmacological targeting of CNS-1 to block its function may ameliorate diseases such as allergy and asthma, which are characterized by an exuberant TH2 response.
The sequence conservation of CNS-1 and its single position in the human genome are features shared by experimentally identified distant regulatory elements 10 . CNS-1 was necessary for the optimal expression of IL-4 during the differentiation of TH2 cells in vitro. In the absence of CNS-1, IL-4 transcription was delayed and protein accumulation diminished. Decreased expression of IL-13 and IL-5 also occurred in the absence of CNS-1 and likely represents a direct effect, rather than a consequence of, diminished IL-4 production. This is because a high concentration of exogenous IL-4 was present during TH2 priming in vitro. Of the three DNase I hypersensitivity sites located in the Il4-Il13 intergenic region, two were induced during TH2 differentiation and were located within CNS-1 3, 33 . Ectopic expression of activated STAT6 or GATA-3 led to chromatin remodeling at the CNS-1 site, and GATA-3 bound a sequence within one of the DNase I hypersensitivity regions 34, 35 . We hypothesize that CNS-1 regulates the accessibility of cell-specific proteins that coordinate stable transcription of Il4 and Il13. Consistent with this interpretation, the expression of reporter genes from a minigene locus containing CNS-1 with additional Il4 promoterenhancer elements was increased by the overexpression of GATA-3 31 . The demonstration of an intermediate phenotype in heterozygous CNS-1 +/-cells suggests a cis-acting effect of CNS-1; this would be consistent with coordinated regulation of the linked Il4, Il13 and Il5 genes revealed in the analysis of T helper clones 12 . The mechanisms by which distant elements function to regulate gene expression remain incompletely defined. The globin gene locus control region, identified as a series of DNase I hypersensitivity sites 5´ of the globin genes, is crucial in regulating the developmental expression of these genes in erythroid cells. Although various models for "looping" or "linking" have been proposed, each envisions a physical reorganization that brings the locus control region into proximity with the appropriately transcribed globin gene by a mechanism coupling erythroid lineage-specific transcription factors to generally expressed chromatinmodifying enzymes that regulate gene accessibility and transcriptional competence 36 . Similar observations have been made in studies of immunoglobulin heavy and light chain enhancers: B cell lineage-and stage-specific regulation of gene expression was linked tightly with demethylation of the immunoglobulin locus [37] [38] [39] . TCRα, β and δ gene enhancer elements similarly influence accessibility by the recombination machinery 40, 41 . The location of CNS-1 at a TH2 condition-dependent DNase I hypersensitivity site 3 , its ability to bind TH2-dependent DNA-binding proteins 33 and, as shown here, its requirement for optimal transcription and stabilization of the TH2 cytokine genes in vitro and in vivo suggest that CNS-1 likely functions to recruit general chromatin remodeling enzymes to these genes.
Factors required for T cell expression of IL4, including GATA-3, c-Maf and STAT6, are either not expressed or are not necessary for IL-4 expression in mast cells [14] [15] [16] . Instead, an element in the second intron of IL4 functions both to enhance transcription and to influence the methylation of IL4 42 . The intronic enhancer serves to bind the mast cell-specific factors PU.1, GATA-1, GATA-2 and, possibly, STAT5a/5b and is required for IL-4 expression in mast cells but not T cells. Unlike mast cells, T cells have the capacity to differentiate into long-lived memory cells that maintain epigenetically modified cytokine effector programs; this ability underlies adaptive, in contrast to innate, immunity. Physical repositioning of cytokine genes in the nucleus accompanies TH subset differentiation 2 . Further studies will be required to establish whether CNS-1 regulation has evolved to confer, in T cells, long-term modification of the locus that might not be necessary in cells of the innate immune system.
Methods
Generation of CNS-1-deficient mice. The targeting construct was amplified from 129/SvJ BAC 111-181 DNA from California Institute of Technology library CitbCJ7 11 using primers for the two homology arms as follows. For the 1.8-kb short arm of CNS-1SA: forward, 5´-TTACCCAGGTCCCCTAACTGG-3´; reverse. 5´-ATGGACACAGCTCTAGGCCTG-3´. For the 5.1 kb long arm of CNS-1LA: forward, 5´-CTGGCTGATTCCTAGCCCTAC-3´; reverse, 5´-GCACTTAGCCTGAGTCACCTG-3´. The targeting vector pPN2T 43 was modified by replacing the existing neomycin selection cassette with a neomycin selection cassette flanked by loxP sites from ploxPneo-1 44 . The resulting targeting vector, ploxPN2T, also contained a tandem array of thymidine kinase expression cassettes for counterselection. The two homology arms were inserted into ploxPN2T on either side of the loxP-flanked neomycin cassette, thereby replacing the 489-bp CNS-1 element with the loxP-flanked neomycin cassette upon correct targeting.
129/SvJ embryonic stem cells (Genome Systems, St Louis, MO) were electroporated with 20 µg of the NotI-linearized targeting construct and subsequently selected in 200 µg/ml of G418 and 0.5 µg/ml of fialuridine for 8 days. Individual clones were isolated, expanded and screened by Southern blot analysis (Fig. 1, probe B) . The 367-bp probe B was amplified by PCR from BAC 111-181 DNA with the following primers. CNS-1b: forward 5′-CAGGT-GACTCAGGCTAAGTGC-3′; reverse 5′-GTCCCAGACTCCAAGTCTTCC-3′. Targeted clones were injected into C57BL/6 blastocysts and chimeric males were bred with C57BL/6 females. Offspring were tested for germline transmission by Southern blot analysis with probe B and heterozygous animals were bred with mice expressing germline Cre recombinase 45 . Offspring were tested for deletion of the neomycin gene by Southern blot analysis with probe C (Fig. 1) . The 218-bp probe C was amplified by PCR from BAC 111-181 DNA with the following primers. CNS-1c: forward 5′-GACACTTGTCCACACACCCTC-3′; reverse 5′-CACCTGAGACTTAGCCCAAGC-3′. Heterozygous CNS-1 -/-mice containing a deleted neomycin cassette were bred with BALB/c females and offspring were screened, by Southern blot analysis, to select for the absence of CNS-1, the neomycin cassette and the cre transgene. These mice were intercrossed to obtain homozygous animals.
T cell purification and activation. Naïve, small, CD62L hi CD4 + T cells were purified to >99% by flow cytometry (MoFlo Multi-Laser; Cytomation, Fort Collins, CO), as described 46 . Where indicated, cells were pre-incubated with CFSE (Molecular Probes, Eugene, OR) as described 2 . Purified T cells were activated under neutral conditions in vitro with 10 6 CD4 + T cells + 5×10 6 irradiated antigen-presenting cells (APCs) prepared from TCR-Cα -/-mice 47 and monoclonal antibodies to TCRβ and CD28 + 50 U/ml of recombinant human IL-2, as described 46 . TH1 conditions included recombinant murine IL-12 (5 ng/ml) and neutralizing IL-4 antibody (mAb 11B11, 20 µg/ml). TH2 conditions included recombinant murine IL-4 (50 ng/ml) and neutralizing IFN-γ antibody (mAb XMG1.2, 50 µg/ml). T cells activated in the absence of APCs were stimulated with the use of tissue culture plates precoated with anti-TCRβ and anti-CD28, as described 46 .
Mast cell purification and activation. Bone marrow cells were flushed from the femurs of CNS-1 -/-and age-matched littermates; c-kit-expressing cells (PharMingen, San Diego, CA) were purified by flow cytometry. Sorted cells were cultured with 1 µg/ml of recombinant murine IL-3 (R&D Systems, Minneapolis, MN). After 5-10 days, the majority of cells had the short cytoplasmic projections, indented nuclei and prominent cytoplasmic granules typical of cultured mast cells, as described 48 . Duplicate aliquots of 10 6 cells were distributed to anti-IL-4-coated plates, activated with 1 µg/ml of ionomycin and incubated undisturbed for 16 h. After washing, captured IL-4 was developed using the ELISPOT assay as described 46 .
Cytokine analysis. Quantitative RT-PCR with real-time fluorogenic 5´-nuclease PCR (TaqMan TM ; PC Applied Biosystems, Foster City, CA) was done as described 2 . Total cellular RNA was extracted, reverse transcribed with oligo(dT)18 priming (Clontech Laboratories, Palo Alto, CA) and amplified with the primers as described 2 . The specific signals for hypoxanthine-guanine phosphoribosyltransferase (HPRT) and IL-4 were at least 45-fold (5.5 cycles) over nonspecific background from RNA without prior reverse transcription. Intracellular cytokine analysis was determined after activation with PMA + ionomycin with brefeldin A blockade as described 2 .
Parasites and infection. Infection with N. brasiliensis was done as described 46 . Third-stage larvae were recovered from the cultured feces of infected rats, washed extensively with PBS, counted and injected subcutaneously in PBS at the base of the tail, injecting 750 worms per animal. After 8 days, the animals were killed and CD4 + T cells from the lungs and mesenteric lymph nodes isolated for cytokine detection as described 46 . Serum was used to quantify IgE by sandwich ELISA as described 46 . The detection limit was 10 ng/ml. Infection with L. major was done as described 46 . Animals were inoculated with 4×10 5 metacyclic promastigotes of L. major (strain WHOM/IR-/173) and the progression of disease monitored weekly with the use of metric calipers to measure the size of the footpad lesions. After 6 weeks, serum was collected for IgE and the draining popliteal lymph nodes used to determine the numbers of IL-4-producing cells by ELISPOT assay. The number of viable parasites in the spleen was analyzed with quantitative twofold dilutions of tissue as described 46 .
Experimental allergic airways disease. Anesthetized mice were sensitized five times by the intranasal administration of 100 µg of A. fumigatus antigen extract at 4 day intervals as described 49 . After 4 days, airway hyperreactivity to escalating doses of acetylcholine was measured in anesthetized mice maintained on rodent ventilators in a whole-body plethysmograph as described 49 . Airway reactivity is standardized to the PC200 (the concentration of acetylcholine in µg/gm body weight that results in a 200% increase over baseline, resting total lung resistance). Lung CD4 + T cells were isolated over Ficoll and used to quantify IL-4-and IL-5-expressing CD4 + T cells after stimulation with PMA + ionomycin and treatment with brefeldin A as described 19 
